- The trend backdrop is active with a 8-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
DEVA
IST
Week ended 07 Aug 2026
Weekly Investor Report
Deva Holding A.S. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
71.45 TRY
1.4%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 4.8% above the Trend Line and sits at 57.5% of its 52-week range. The latest completed week returned 1.4%, after a 1.1% four-week move. The latest news-sentiment score is 50/100.
Setup score
56
out of 100
Latest Close
71.45 TRY
7 Aug 2026
1W Return
1.4%
latest completed week
4W Return
1.1%
short-term follow-through
12W Return
7.0%
quarterly tape
Trend Breadth
55.8%
29 of 52 weeks active
Volume Ratio
1.6x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.4%
Latest completed week; four-week move 1.1%.
Indicator stack
58/68
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 4.8% above the Trend Line and sits at 57.5% of its 52-week range. The latest completed week returned 1.4%, after a 1.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5812-week average 0.47
12-week confirmation
Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.58Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 1.1% over four weeks, 7.0% over 12 weeks, and 12.7% over one year. The current trend has remained active for 8 consecutive weeks.
Performance by holding period
Active trend streak8 weeks
Active weeks in one year29
Trend breadth55.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.94Latest activity-pressure read.
Pressure change13.0%Four-week change in activity pressure.
Leadership-3.42Latest relative-leadership reading.
RS change61.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-12.6%Distance below the 52-week high.
13-week volatility4.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+9.0%Week of 10 Apr.
Worst week-8.6%Week of 6 Mar.
Latest week+1.4%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains8
Flat weeks0
Modest losses7
Sharp losses6
Recent vol4.5%13-week weekly-return volatility.
Base vol4.6%52-week weekly-return volatility.
Up/down split32/20Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -4.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTR Healthcare
4-week rank5 / 15
Group average-1.9%
Trend breadth40.0%
Trend40.0%active weekly trend signals
MD33.3%positive activity pressure
RS26.7%positive relative leadership
Four-week leaders
IndustryTR Drug Manufacturers - Specialty & Generic
4-week rank2 / 4
Group average-1.2%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD50.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape56/100
Trend, activity pressure, participation, and risk combine to a 56/100 tape read.
Indicator analysis56/100Latest 12-week confirmation: trend 11/12, activity pressure 7/12, relative leadership 1/12.
Activity pressure 0.58; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 71.45 TRY | 1.4% | 68.17 TRY | 71.46 TRY | 0.94 | -3.42 | 2.5M | On |
| 31 Jul 2026 | 70.45 TRY | -6.8% | 67.90 TRY | 71.47 TRY | 0.99 | -2.70 | 2.0M | On |
| 24 Jul 2026 | 75.60 TRY | 2.8% | 67.66 TRY | 71.43 TRY | 1.12 | 0.48 | 3.1M | On |
| 17 Jul 2026 | 73.55 TRY | 4.1% | 67.23 TRY | 71.33 TRY | 0.90 | -2.64 | 1.4M | On |
| 10 Jul 2026 | 70.65 TRY | -4.1% | 66.84 TRY | 71.24 TRY | 0.83 | -8.92 | 1.9M | On |
| 3 Jul 2026 | 73.70 TRY | 5.6% | 66.55 TRY | 71.12 TRY | 0.55 | -5.92 | 541.4K | On |
| 26 Jun 2026 | 69.80 TRY | -1.0% | 66.12 TRY | 70.97 TRY | 0.14 | -10.29 | 257.3K | On |
| 19 Jun 2026 | 70.50 TRY | 8.4% | 65.77 TRY | 70.84 TRY | -0.19 | -12.52 | 857.7K | On |
| 12 Jun 2026 | 65.05 TRY | -0.5% | 65.52 TRY | 70.67 TRY | -0.58 | -14.97 | 512.0K | Off |
| 5 Jun 2026 | 65.35 TRY | 0.5% | 65.43 TRY | 70.54 TRY | -0.56 | -13.37 | 267.7K | On |
| 29 May 2026 | 65.00 TRY | 1.3% | 65.56 TRY | 70.42 TRY | -0.31 | -14.01 | 478.8K | On |
| 22 May 2026 | 64.15 TRY | -3.9% | 65.75 TRY | 70.29 TRY | -0.25 | -16.40 | 1.8M | On |
| 15 May 2026 | 66.75 TRY | -7.2% | 65.97 TRY | 70.13 TRY | -0.12 | -16.80 | 4.8M | On |
| 8 May 2026 | 71.95 TRY | 8.9% | 66.10 TRY | 69.95 TRY | -0.12 | -14.87 | 6.4M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.